The prestroke use of vitamin K antagonists for atrial fibrillation – trends over 15 years

Publisher： John Wiley & Sons Inc

E-ISSN： 1742-1241|69|2|180-185

ISSN： 1368-5031

Source： INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol.69, Iss.2, 2015-02, pp. : 180-185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of non‐vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 11, 2015-11 ,pp. : 1341-1348

John Wiley & Sons Inc

Access to resources Recommend Favorite

Screening for atrial fibrillation in patients aged 65 years or over attending annual flu vaccination clinics at a single general practice

By Rhys G.C.  

Quality in Primary Care, Vol. 21, Iss. 2, 2013-05 ,pp. : 131-140

Radcliffe Press

Access to resources Recommend Favorite

Non‐vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta‐analysis of randomized trials

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 11, 2015-11 ,pp. : 1192-1200

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of Vitamin K Antagonists and Brain Volumetry in Older Adults: Preliminary Results From the GAIT Study

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 10, 2015-10 ,pp. : 2199-2202

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vitamin K antagonists' use and fracture risk: results from a systematic review and meta‐analysis

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 9, 2015-09 ,pp. : 1665-1675

John Wiley & Sons Inc

Access to resources Recommend Favorite